What is Augment Therapy?
Augment Therapy operates at the intersection of digital health and augmented reality, providing a specialized platform designed to enhance patient engagement during physical therapy. By utilizing mobile-based augmented reality, the company enables clinicians to deliver therapeutic exercises in a more interactive and immersive format. This approach addresses critical challenges in patient adherence and recovery outcomes, positioning the firm as a disruptive force in the health tech sector. The platform is engineered to bridge the gap between traditional clinical care and modern digital engagement, ensuring that patients remain motivated throughout their rehabilitation journey.
How much funding has Augment Therapy raised?
Augment Therapy has raised a total of $2.4M across 2 funding rounds:
Angel/Seed
$1.4M
Other Financing Round
$1M
Angel/Seed (2021): $1.4M with participation from BlueTree Allied Angels, KidsX Investor Network, VisionTech Partners, and Next Act Fund
Other Financing Round (2023): $1M led by CareSource
Key Investors in Augment Therapy
BlueTree Allied Angels
A regional group of accredited investors focused on early-stage companies, providing both capital and operational mentorship to mitigate investment risk.
VisionTech Partners
A prominent Midwest-based angel network that conducts rigorous due diligence to identify and support high-potential startups with industry insights.
Next Act Fund
An investment organization dedicated to fostering economic growth by backing early-stage, women-led companies and promoting personal wealth creation.
What's next for Augment Therapy?
With the recent influx of capital, Augment Therapy is poised to scale its operations and expand its footprint within the enterprise health market. The strategic focus will likely center on deepening clinical partnerships and enhancing the platform's feature set to meet the rigorous demands of large-scale healthcare providers. As the company matures, the emphasis will shift toward proving long-term clinical efficacy and securing broader adoption across diverse patient populations. This phase of growth is critical for establishing the company as a standard-bearer for digital therapeutic interventions, potentially setting the stage for future expansion into new clinical domains or international markets.
See full Augment Therapy company page
